Answers are grounded in this paper and cite their sources.
This research demonstrates synergistic tumor treatment using lattice distortion-mediated piezoelectric and chemodynamic therapies, suggesting a novel strategy.
Reactive oxygen species (ROS)-mediated sonodynamic therapy (SDT) and chemodynamic therapy (CDT) have emerged as a research hotspot in tumor treatment due to their advantages in spatiotemporal controllability. However, monomodal therapy suffers from inherent limitations. SDT is constrained by insufficient piezoelectric performance and the transient nature of ROS generation, while CDT is plagued by low catalytic efficiency, severely hindering clinical translation. To address these issues, this study constructs a polyethylene glycol-encapsulated iron-doped bismuth fluoride (BiF₃:Fe) nanosystem (BFFP) to achieve synergistic SDT-long-term CDT and induce cancer cell ferroptosis. Iron doping disrupts the central symmetry of the BiF₃ crystal lattice, inducing lattice distortion and enhancing piezoelectric performance. Under ultrasound irradiation, BFFP efficiently generates •OH and •O₂⁻ via the piezoelectric effect, enabling instantaneous ROS bursts for SDT. In the acidic tumor microenvironment, BFFP gradually degrades to expose active Fe²⁺/Fe³⁺ sites, which catalyze the sustained generation of •OH through Fenton-like reactions using endogenous H₂O₂, accomplishing long-term CDT. This instantaneous plus long-term ROS generation pattern synergistically depletes glutathione, inhibits glutathione peroxidase 4 activity, promotes accumulation of lipid peroxidation, and induces mitochondrial damage, ultimately triggering ferroptosis in tumor cells. This work provides a material paradigm and technical pathway for ROS-mediated long-term synergistic tumor therapy.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: